Immunomodulating antibodies in the treatment of metastatic melanoma: The experience with anti-CTLA-4, anti-CD137, and anti-PD1

By Simeone Ester   Ascierto Paolo A.  

Journal of Immunotoxicology, Vol. 9, Iss. 3, 2012-09 ,pp. : 241-247

Informa Healthcare

Access to resources Recommend Favorite

Human antibodies in cancer and autoimmune disease

By Ditzel Henrik  

Immunologic Research, Vol. 21, Iss. 2-3, 2000-06 ,pp. : 185-193

Humana Press, Inc

Access to resources Recommend Favorite

Effect of Long-Term Anti-CD4 or Anti-CD8 Treatment on the Development of lpr CD4 CD8 Double Negative T Cells and of the Autoimmune Syndrome in MRL- lpr / lpr Mice

By Merino R.   Fossati L.   Iwamo to M.   Takahashi S.   Lemoine R.   Ibnou-Zekri N.   Pugliatti L.   Merino J.   Izui S.  

Journal of Autoimmunity, Vol. 8, Iss. 1, 1995-01 ,pp. : 33-45

Academic Press

Access to resources Recommend Favorite

Anti-CD20 in Targeting B Lymphocytes for the Treatment of Autoimmune Diseases: Clinical Benefits and Insights into the Role of B Lymphocytes in Pathophysiology

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 8, Iss. 3, 2008-09 ,pp. : 222-234

Bentham Science Publishers

Access to resources Recommend Favorite

Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies

By Mottram P.L.   Murray-Segal L.J.   Han W.   Maguire J.   Stein-Oakley A.N.  

Transplant Immunology, Vol. 10, Iss. 1, 2002-06 ,pp. : 63-72

Elsevier

Access to resources Recommend Favorite